News ArticleMetropolis Healthcare Ltd Reports INR 4,169 Million Revenue for Q2 2026 and Declares INR 1 Interim Dividend
Unaudited results for Q2 and H1 FY 2026-27 show net profit of INR 687.51 million for the quarter with dividend payable November 09, 2026
Metropolis Healthcare Limited announced its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, reporting INR 4,169.34 million revenue in Q2 and a consolidated revenue of INR 7,892.18 million for H1. The company declared an interim dividend of INR 1 per equity share for FY 2026-27, payable to shareholders on record as of November 9, 2026.
Metropolis Healthcare Limited
Corporate Action
Metropolis Healthcare Limited released its unaudited financial results for the quarter and half year ended September 30, 2026, reporting revenues of INR 4,169.34 million in Q2 and total income of INR 8,033.92 million for H1. The company declared an interim dividend of INR 1 per equity share for fiscal 2026-27, with the record date set as November 09, 2026.
The company's standalone net profit from continuing operations for Q2 FY 2026-27 was INR 687.51 million, compared to INR 506.54 million in the previous quarter and INR 464.90 million for Q2 last year.
For the half year ended September 30, 2026, Metropolis Healthcare posted a net profit of INR 1,194.05 million against INR 818.49 million for the corresponding period last year.
Total revenue from operations in Q2 was INR 4,169.34 million, increased from INR 3,722.84 million in Q1 and INR 3,554.57 million in Q2 last year.
The board approved an interim dividend of INR 1 per equity share with a face value of INR 2, payable within 30 days of declaration to shareholders on record as of November 09, 2026.
The financial results and the limited review report from statutory auditors have been made available on the company’s website.
Highlights
- Standalone revenue from operations in Q2 FY 2026-27: INR 4,169.34 million
- Net profit from continuing operations in Q2: INR 687.51 million
- Total income for H1 FY 2026-27: INR 8,033.92 million
- Interim dividend declared: INR 1 per equity share (face value INR 2) for FY 2026-27
- Dividend record date: November 09, 2026, with payment within 30 days
- Limited review by Deloitte Haskins & Sells confirmed no material misstatements
Key Data Snapshot
What happened
- Metropolis Healthcare approved its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026.
- The Board declared an interim dividend of INR 1 per equity share for the financial year 2026-27.
- Dividend record date is set for November 09, 2026, with payment to be made within 30 days.
- The results were reviewed by Deloitte Haskins & Sells with no material modifications noted.
Financial performance
- Standalone revenue from operations in Q2 2026 was INR 4,169.34 million, up from INR 3,722.84 million in Q1 2026.
- Net profit for Q2 2026 stood at INR 687.51 million from continuing operations.
- Total income including other income for Q2 was INR 4,259.22 million.
- For H1 2026-27, revenue from operations was INR 7,892.18 million and net profit from continuing operations was INR 1,194.05 million.
- The company’s earnings per share for continuing operations in Q2 was INR 3.32 basic and INR 3.29 diluted.
Regulatory and governance context
- Financial results were approved in the Board meeting held on November 03, 2026.
- The financial statements comply with Indian Accounting Standard 34 on Interim Financial Reporting and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
- Limited review report from the statutory auditor Deloitte Haskins & Sells confirms compliance and accuracy of interim financial information.
Highlights
- Standalone revenue from operations in Q2 FY 2026-27: INR 4,169.34 million
- Net profit from continuing operations in Q2: INR 687.51 million
- Total income for H1 FY 2026-27: INR 8,033.92 million
- Interim dividend declared: INR 1 per equity share (face value INR 2) for FY 2026-27
- Dividend record date: November 09, 2026, with payment within 30 days
- Limited review by Deloitte Haskins & Sells confirmed no material misstatements
Disclosures
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
- Indian Accounting Standard 34 - Interim Financial Reporting
More News on Corporate Action
View allLatest corporate announcements and market updates in Corporate Action.
Power Finance Corporation Ltd Declares Rs.4.10 Second Interim Dividend along with Q2 and H1 FY2026-27 Unaudited Financial Results
Power Finance Corporation Ltd released its unaudited standalone and consolidated financial statements for the quarter and half year ended 30 September 2026 and announced a second interim dividend of Rs.4.10 per equity share for FY 2026-27.
Read Full Story
InterGlobe Aviation Allots 1,000 Shares on ESOP Exercise Under 2023 Scheme
InterGlobe Aviation Limited allotted 1,000 equity shares at Rs. 10 each on November 4, 2026, upon exercise of vested employee stock options under its 2023 ESOP scheme.
Read Full Story
IndiGrid Infrastructure Trust Arranges INR 1,000 Crore Term Loan Facility Executed on October 30, 2026
IndiGrid Infrastructure Trust, through its Investment Manager IndiGrid Investment Managers Limited, finalized a term loan facility agreement worth INR 1,000 Crore on October 30, 2026, with the option to draw funds in multiple tranches.
Read Full Story
